-
(单词翻译:双击或拖选)
Malaria1 Vaccine2 Shows Acceptable Safety, Efficacy Results
An international health alliance working to develop a vaccine against malaria says one of its most advanced vaccines3, called RTS,S, shows promising4 results. After two years of human clinical trials in Africa, the PATH Malaria Vaccine Initiative and its collaborators report the vaccine provides protection against malaria for children aged5 five to 17 months.
Scientists working on the world’s first-ever malaria vaccine are calling the RTS,S trials a significant milestone6.
“For 40 years people have been trying to develop malaria vaccine and here we are,” said Dr. Christian7 Loucq, the director of Malaria Vaccine Initiative, which is an international non-profit group involved in assessing the safety and effectiveness of the new vaccine. Thousands of children in seven countries in Africa received the vaccine. Investigators8 found that in vaccinated9 children, the risk of severe and clinical malaria was reduced by half.
“Phase Three is where you look into efficacy and safety for which we had consistent results and we are very happy and encouraged to move on,” said Dr. Daniel Ansong, a pediatrician and researcher at one of the clinical-trial sites in Ghana.
Dr. Ansong believes the vaccine will be a valuable new weapon in the global war on malaria.
Critics note that in the field trials, the new vaccine was only 47 percent effective against severe malaria, a level of protection they say should be higher. But pediatricians say that with malaria killing10 800,000 children every year, even this level of efficacy could save thousands of lives.
Dr. Joe Cohen is co-inventor of the RTS,S vaccine and a researcher at the drug companty GlaxoSmith-line. It has invested $300 million in malaria vaccine development.
Cohen says developing a vaccine against malaria has been a major scientific challenge. “The problem, I think, is the parasite11 itself. Malaria parasite - parasites12 in general - very complex organisms, with complex DNA13 makeup14 with many thousands of genes15, in contrast to bacteria or viruse,” he said.
GlaxoSmith-Kline says it expects to invest an additional $50 to 100 million in the vaccine program. Researchers say they will start testing the vaccine on larger populations after the successful completion of ongoing16 Phase Three trials.
The developers plan to submit the final results of the vaccine trials to the World Health Organization by 2014. Their hope is that the WHO will recommend that the malaria vaccine become a routine part of all future childhood immunization programs.
1 malaria | |
n.疟疾 | |
参考例句: |
|
|
2 vaccine | |
n.牛痘苗,疫苗;adj.牛痘的,疫苗的 | |
参考例句: |
|
|
3 vaccines | |
疫苗,痘苗( vaccine的名词复数 ) | |
参考例句: |
|
|
4 promising | |
adj.有希望的,有前途的 | |
参考例句: |
|
|
5 aged | |
adj.年老的,陈年的 | |
参考例句: |
|
|
6 milestone | |
n.里程碑;划时代的事件 | |
参考例句: |
|
|
7 Christian | |
adj.基督教徒的;n.基督教徒 | |
参考例句: |
|
|
8 investigators | |
n.调查者,审查者( investigator的名词复数 ) | |
参考例句: |
|
|
9 vaccinated | |
[医]已接种的,种痘的,接种过疫菌的 | |
参考例句: |
|
|
10 killing | |
n.巨额利润;突然赚大钱,发大财 | |
参考例句: |
|
|
11 parasite | |
n.寄生虫;寄生菌;食客 | |
参考例句: |
|
|
12 parasites | |
寄生物( parasite的名词复数 ); 靠他人为生的人; 诸虫 | |
参考例句: |
|
|
13 DNA | |
(缩)deoxyribonucleic acid 脱氧核糖核酸 | |
参考例句: |
|
|
14 makeup | |
n.组织;性格;化装品 | |
参考例句: |
|
|
15 genes | |
n.基因( gene的名词复数 ) | |
参考例句: |
|
|
16 ongoing | |
adj.进行中的,前进的 | |
参考例句: |
|
|